The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-Hydroxy-N-(3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)phenyl)heptanamide ID: ALA3287959
PubChem CID: 90681034
Max Phase: Preclinical
Molecular Formula: C22H25N3O3
Molecular Weight: 379.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nnc(-c3cccc(NC(=O)CCCCCCO)c3)o2)cc1
Standard InChI: InChI=1S/C22H25N3O3/c1-16-10-12-17(13-11-16)21-24-25-22(28-21)18-7-6-8-19(15-18)23-20(27)9-4-2-3-5-14-26/h6-8,10-13,15,26H,2-5,9,14H2,1H3,(H,23,27)
Standard InChI Key: INCXLOIITHWYDT-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
2.4319 -2.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4306 -3.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1455 -3.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8619 -3.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8590 -2.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1437 -2.2955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7173 -2.2959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5770 -3.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5469 -4.7688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3231 -5.0486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8289 -4.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3655 -3.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6535 -4.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0406 -5.1502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8644 -5.1767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3002 -4.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9061 -3.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0836 -3.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2536 -5.9040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0782 -5.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4675 -6.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5134 -5.2298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2920 -6.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6813 -7.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5058 -7.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8951 -8.1658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7197 -8.1924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1090 -8.9197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
4 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
15 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.46Molecular Weight (Monoisotopic): 379.1896AlogP: 4.59#Rotatable Bonds: 9Polar Surface Area: 88.25Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.84CX Basic pKa: ┄CX LogP: 3.80CX LogD: 3.80Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.04
References 1. Liao BR, He HB, Yang LL, Gao LX, Chang L, Tang J, Li JY, Li J, Yang F.. (2014) Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles., 83 [PMID:24946215 ] [10.1016/j.ejmech.2014.06.011 ] 2. Kerru N, Singh-Pillay A, Awolade P, Singh P.. (2018) Current anti-diabetic agents and their molecular targets: A review., 152 [PMID:29751237 ] [10.1016/j.ejmech.2018.04.061 ]